Astrazeneca (AZN) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $166.68, +2.87% vs the prior close of $162.03.
- Volume 4.40M shares, 1.4x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
AZN rises 2.9% to $166.68. Closed at $166.68, +2.87% vs the prior close of $162.03. Day range $166.49–$169.81, opened at $167.69.
AZN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — AZN rises 2.9% to $166.68
- Closed at $166.68, +2.87% vs the prior close of $162.03. Day range $166.49–$169.81, opened at $167.69.
- Volume was 4.40M shares, 1.4x its 50-day average of 3.15M.
- Price is +2.9% vs its 50-day average ($162.05) and -7.9% vs its 200-day average ($181.05).
- 52-week range $153.41–$212.71; today's close sits at 22% of that range, 21.6% below the 52-week high.
Oct 14, 2026 — AZN jumps 4.0% to $162.03
- Closed at $162.03, +3.99% vs the prior close of $155.82. Day range $158.31–$162.71, opened at $158.71.
- Volume was 3.33M shares, 1.0x its 50-day average of 3.24M.
- Price is +0.1% vs its 50-day average ($161.94) and -10.5% vs its 200-day average ($181.14).
- 52-week range $153.41–$212.71; today's close sits at 15% of that range, 23.8% below the 52-week high.
Oct 13, 2026 — AZN dips 1.6% to $155.82, a 1-month low
- Closed at $155.82, -1.59% vs the prior close of $158.33. Day range $154.00–$160.83, opened at $160.76.
- Volume was 3.11M shares, 0.9x its 50-day average of 3.51M.
- Price is -3.7% vs its 50-day average ($161.81) and -14.0% vs its 200-day average ($181.26).
- 52-week range $153.41–$212.71; today's close sits at 4% of that range, 26.7% below the 52-week high.
Oct 12, 2026 — AZN dips 0.5% to $158.33
- Closed at $158.33, -0.55% vs the prior close of $159.20. Day range $157.60–$159.44, opened at $159.44.
- Volume was 2.86M shares, 0.8x its 50-day average of 3.48M.
- Price is -2.2% vs its 50-day average ($161.86) and -12.7% vs its 200-day average ($181.40).
- 52-week range $153.41–$212.71; today's close sits at 8% of that range, 25.6% below the 52-week high.
Oct 9, 2026 — AZN ends flat (+0.3%) to $159.20
- Closed at $159.20, +0.26% vs the prior close of $158.78. Day range $158.53–$160.07, opened at $159.45.
- Volume was 2.12M shares, 0.6x its 50-day average of 3.49M.
- Price is -1.8% vs its 50-day average ($162.08) and -12.3% vs its 200-day average ($181.53).
- 52-week range $153.41–$212.71; today's close sits at 10% of that range, 25.2% below the 52-week high.
Oct 8, 2026 — AZN dips 0.8% to $158.78
- Closed at $158.78, -0.84% vs the prior close of $160.12. Day range $156.72–$160.05, opened at $159.80.
- Volume was 3.49M shares, 1.0x its 50-day average of 3.46M.
- Price is -2.2% vs its 50-day average ($162.33) and -12.6% vs its 200-day average ($181.65).
- 52-week range $153.41–$212.71; today's close sits at 9% of that range, 25.4% below the 52-week high.
Oct 7, 2026 — AZN rises 1.0% to $160.12
- Closed at $160.12, +0.95% vs the prior close of $158.61. Day range $158.53–$161.29, opened at $159.12.
- Volume was 2.46M shares, 0.7x its 50-day average of 3.51M.
- Price is -1.5% vs its 50-day average ($162.62) and -11.9% vs its 200-day average ($181.77).
- 52-week range $153.41–$212.71; today's close sits at 11% of that range, 24.7% below the 52-week high.
Oct 6, 2026 — AZN rises 1.3% to $158.61
- Closed at $158.61, +1.33% vs the prior close of $156.53. Day range $156.26–$159.96, opened at $159.80.
- Volume was 2.05M shares, 0.6x its 50-day average of 3.54M — lighter than usual.
- Price is -2.6% vs its 50-day average ($162.86) and -12.8% vs its 200-day average ($181.88).
- 52-week range $153.41–$212.71; today's close sits at 9% of that range, 25.4% below the 52-week high.
Oct 5, 2026 — AZN ends flat (-0.2%) to $156.53, a 1-month low, 6 down days in a row
- Closed at $156.53, -0.24% vs the prior close of $156.90. Day range $154.81–$157.20, opened at $156.76.
- Volume was 2.26M shares, 0.6x its 50-day average of 3.54M.
- Price is -4.0% vs its 50-day average ($163.08) and -14.0% vs its 200-day average ($181.98).
- 52-week range $153.41–$212.71; today's close sits at 5% of that range, 26.4% below the 52-week high.
- That makes 6 straight losses.
- SEC filings that day: 6-K.
Oct 2, 2026 — AZN dips 0.5% to $156.90, a 1-month low, 5 down days in a row
- Closed at $156.90, -0.51% vs the prior close of $157.70. Day range $156.41–$158.80, opened at $158.46.
- Volume was 3.04M shares, 0.9x its 50-day average of 3.53M.
- Price is -3.9% vs its 50-day average ($163.34) and -13.8% vs its 200-day average ($182.11).
- 52-week range $153.41–$212.71; today's close sits at 6% of that range, 26.2% below the 52-week high.
- That makes 5 straight losses.
- SEC filings that day: 6-K.
AZN latest news & SEC filings
Every SEC filing by or about AZN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sharma Mani received an award of 2 shares at $159.80 (≈$320) on Oct 6, 2026; now holds 19,291
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 2, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 1, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 1, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 29, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 23, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 21, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 21, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 18, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 15, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 15, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 14, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 11, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sharma Mani bought 20 shares at $160.57 (≈$3.25K) on Aug 8, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade AZN
- How much it moves: over the last 20 sessions the average daily move was 1.25% (largest 4.0%).
- Liquidity: about 2.79M shares (≈$464.53M) trade per day on average.
- 52-week position: $166.68 vs a range of $153.41–$212.71 (22% of the range).
- Dividends: last ex-dividend date Feb 19, 2026 ($2.153/share); 1 payments in the past 12 months.
- Splits: 1:2 on Feb 2, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 1 sales; latest: Mani Sharma bought 20 shares on Aug 8, 2026.
- Latest filings: 6-K Oct 5, 2026; 6-K Oct 2, 2026; 6-K Oct 1, 2026.
- Listing: NYSE · industry: Pharmaceutical Preparations.
AZN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 167.69 | 169.81 | 166.49 | 166.68 | 4.40M |
| Oct 14, 2026 | 158.71 | 162.71 | 158.31 | 162.03 | 3.33M |
| Oct 13, 2026 | 160.76 | 160.83 | 154.00 | 155.82 | 3.11M |
| Oct 12, 2026 | 159.44 | 159.44 | 157.60 | 158.33 | 2.86M |
| Oct 9, 2026 | 159.45 | 160.07 | 158.53 | 159.20 | 2.12M |
| Oct 8, 2026 | 159.80 | 160.05 | 156.72 | 158.78 | 3.49M |
| Oct 7, 2026 | 159.12 | 161.29 | 158.53 | 160.12 | 2.46M |
| Oct 6, 2026 | 159.80 | 159.96 | 156.26 | 158.61 | 2.05M |
| Oct 5, 2026 | 156.76 | 157.20 | 154.81 | 156.53 | 2.26M |
| Oct 2, 2026 | 158.46 | 158.80 | 156.41 | 156.90 | 3.04M |
| Oct 1, 2026 | 160.77 | 161.33 | 157.54 | 157.70 | 3.38M |
| Sep 30, 2026 | 164.47 | 164.48 | 161.46 | 161.47 | 2.23M |
| Sep 29, 2026 | 165.09 | 166.47 | 163.24 | 164.21 | 3.37M |
| Sep 28, 2026 | 165.69 | 167.52 | 165.39 | 166.15 | 1.73M |
| Sep 25, 2026 | 166.16 | 166.81 | 164.60 | 166.58 | 2.07M |
| Sep 24, 2026 | 162.91 | 166.25 | 162.91 | 164.56 | 3.19M |
| Sep 23, 2026 | 166.58 | 167.59 | 163.33 | 163.33 | 2.36M |
| Sep 22, 2026 | 167.84 | 169.35 | 166.74 | 168.37 | 2.31M |
| Sep 21, 2026 | 168.45 | 169.00 | 167.11 | 168.10 | 2.94M |
| Sep 18, 2026 | 167.15 | 167.83 | 165.54 | 166.08 | 3.06M |
About Astrazeneca
Astrazeneca (AZN) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CAMBRIDGE. State of incorporation: United Kingdom. Fiscal year ends December 31. SEC CIK 901832.
AZN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Mani Sharma | See Remarks | Sep 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 8, 2026 | Mani Sharma | Buy | 20 | $160.57 |
| May 20, 2026 | Mani Sharma | Sale | 11,893 | $185.78 |
AZN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
AZN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on AZN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.